Results 1 to 10 of about 282,732 (163)

Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies

open access: yesViruses, 2011
Hepatitis C virus (HCV) represents a major public health problem, affecting 3% of the world’s population. The majority of infected individuals develop chronic hepatitis, which can progress to cirrhosis and hepatocellular carcinoma.
Arvind H. Patel   +2 more
doaj   +3 more sources

Prevalence of hepatitis C in the adult Mexican population: National Survey of Health and Nutrition 2018

open access: yesThe Lancet Regional Health. Americas, 2022
Summary: Background: Hepatitis C is a preventable and treatable disease that has been declared a public health problem. In 2012, the prevalence of HCV serum anti-bodies in the Mexican adult population aged 20 to 49 years was 0·30%.
Martha Carnalla   +10 more
doaj   +1 more source

Predicting factors of present hepatitis C virus infection among patients positive for the hepatitis C virus antibody [PDF]

open access: yesClinical and Molecular Hepatology, 2013
Background/AimsTo identify the predicting factors of present hepatitis C virus (HCV) infection among patients with positivity for antibodies to HCV (anti-HCV).MethodsWe analyzed patients who showed positive enzyme immunoassay (EIA) results and performed ...
Chi Hoon Lee   +10 more
doaj   +1 more source

Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR. [PDF]

open access: yesPLoS ONE, 2015
BACKGROUND AND AIMS:Healthcare workers (HCW) have an increased risk of exposure to infectious diseases and are a potential source of infections for their patients.
Antony P Black   +5 more
doaj   +1 more source

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents [PDF]

open access: yes, 2014
Hepatitis C virus (HCV) is transmitted between hepatocytes via classical cell entry but also uses direct cell-cell transfer to infect neighboring hepatocytes.
A Owsianka   +72 more
core   +10 more sources

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment [PDF]

open access: yes, 2010
Background Early detection of nonresponders to hepatitis C therapy limits unnecessary exposure to treatment and its side-effects. A recent algorithm combining baseline anti-NS4a antibodies and on-treatment quantitative PCR identified nonresponders to a ...
de Knegt, Robert J   +8 more
core   +1 more source

Interleukins as one of possible markers for early diagnosis of viral hepatitis c at first year old children

open access: yesЖурнал инфектологии, 2014
The article presents the results of the research of improvement one of possible methods of early diagnostics of viral hepatitis C at first-year old children, who born from mothers with chronic viral hepatitis C, in blood anti-HCV IgG are revealed, based ...
T. A. Kirsanova
doaj   +1 more source

The Role of Specific Cellular Immune System in Chronic Hepatitis C [PDF]

open access: yes, 2004
Hepatitis C virus is a RNA virus with very high speed replication. The clinical course of chronic hepatitis C is frequently asymptomatic like other hepatitis viruses.
Akbar, N. (Nurul)   +4 more
core   +1 more source

Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: Seroprevalence, risk factors and related chronic liver diseases

open access: yesJournal of Infection and Public Health, 2013
Summary: Background and aim: Prisons in Egypt do not currently screen for blood-borne viruses, and there are no statistics concerning the prevalence of hepatitis C virus, hepatitis B virus or human immunodeficiency virus among prisoners.
Hala I. Mohamed   +6 more
doaj   +1 more source

Host neutralizing responses and pathogenesis of hepatitis C virus infection. [PDF]

open access: yes, 2008
International audienceThe recent development of novel model systems for the early steps of hepatitis C virus (HCV) infection has rapidly advanced our knowledge of antibody-mediated virus neutralization in patients with acute and chronic hepatitis C. This
Baumert, Thomas,   +2 more
core   +3 more sources

Home - About - Disclaimer - Privacy